4OR, if it is then the reason is that PtdSer targeting as long as it includes an immune response (the FC-Gamma binding) will NEVER be approaved and will be blocked by BP.
In China it will be on the market within less then 5 Years, if not 2 years.
Simple, you fly in and having treatment in China brings medical Tourism.
It will be cheaper then in the US and China has shown that with Honk-Kong Macao, etc they know how to open that door.
Probably to only way to beat BP at its own game.
AIMO
Market Data 
Markets 
AI
